Blood Transfusion Diagnostics Market to reach US$ 8.7 Billion by 2032; Blood Grouping to expand at a 5.8% CAGR: Fact.MR
07. Dezember 2022 14:00 ET
|
FACT.MR
Rockville, Dec. 07, 2022 (GLOBE NEWSWIRE) -- According to a recent report by Fact.MR, a market research and competitive intelligence provider, market of blood transfusion diagnostics is predicted to...
Quotient Limited Announces CFO Transition
02. November 2016 16:15 ET
|
Quotient Limited
JERSEY, Channel Islands, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, announced today that the company and Stephen Unger, Chief Financial...
Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ™ and Second Quarter Fiscal 2017 Financial Results
31. Oktober 2016 16:15 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported further progress on the commercial scale-up of...
Quotient Limited Announces Booth Tour at the 2016 AABB Annual Meeting and Provides Update of Expected Timing of Internal Evaluation Study Results
21. Oktober 2016 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s executive management team will...
Quotient Limited to Report Second Quarter Fiscal 2017 Financial Results and Host Conference Call
17. Oktober 2016 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal...
Quotient Limited Announces $120 Million Secured Debt Financing
14. Oktober 2016 16:01 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (“Quotient”) (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the completion of a private...
Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays
08. September 2016 16:05 ET
|
Quotient Limited
MosaiQTM manufacturing system operating in accordance with design requirements Ongoing evaluation of MosaiQTM methodology continues to demonstrate concordance levels in excess of 99.0% for key blood...
Quotient Limited Reports Further Progress on the Commercial Scale-up of MosaiQ™ and First Quarter Fiscal 2017 Financial Results
08. August 2016 16:15 ET
|
Quotient Limited
Facility modification completed – humidity control successfully resolved issue previously impacting final assembly of MosaiQ™ consumablesValidation of the initial manufacturing system for MosaiQ™...
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
03. August 2016 16:05 ET
|
Quotient Limited
JERSEY, Channel Islands, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the closing of its underwritten public offering...
Quotient Limited to Report First Quarter Fiscal 2017 Financial Results and Host Conference Call
01. August 2016 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first...